Abstract
To clarify age-related changes of 67 macro- and microelement contents in prostate gland of adult and geriatric males, a quantitative measurement by five analytical methods was performed. The nonhyperplastic prostate glands of 65 subjects (European-Caucasian aged 21–87 years) were investigated by energy dispersive X-ray fluorescence (EDXRF), instrumental neutron activation analysis with high resolution spectrometry of short-lived radionuclides (INAA-SLR), instrumental neutron activation analysis with high resolution spectrometry of long-lived radionuclides (INAA-LLR), inductively coupled plasma atomic emission spectrometry (ICP-AES), and inductively coupled plasma mass spectrometry (ICP-MS). The prostates were obtained at autopsy from subjects who died from acute illness (cardiac insufficiency, stroke, embolism of pulmonary artery, alcohol poisoning) and trauma. None of the subjects had any symptoms of prostatic disease, and all prostates were classified as histologically normal. The combination of nuclear (EDXRF, INAA-SLR, and INAA-LLR) and inductively coupled plasma (ICP-AES and ICP-MS) analytical methods allowed estimation of the contents of 67 chemical elements and precisely determined the mass fraction of 54 elements in the tissue samples of nonhyperplastic adult and geriatric prostate glands. This work’s results reveal that there is a significant increase with age of Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, U, and Zn mass fractions in the prostate tissue of healthy individuals of ages from 21 to 60 years, as well as an increase in Ba from age 61 up to 87 years. It implies that an age-related increase and excess in Ba, Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, U, and Zn mass fraction in prostatic tissue may be one of the main factors in the etiology of benign prostatic hyperplasia (BPH) and prostate carcinoma (PCa).
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The human prostate gland is the only internal organ that continues to enlarge throughout adulthood [1, 2]. The prevalence of benign enlargement of the prostate (benign prostatic hyperplasia—BPH) and prostate carcinoma (PCa) rises sharply with age. For example, the prevalence of PCa is approximately three orders of magnitude higher for males older than 40 years, compared with younger males. To date, we have no precise knowledge of the biochemical processes underlying the etiology and pathogenesis of BPH and PCa. There are a few hypotheses on the subject [3–11]. Among these hypotheses, the possible role of the oxidative stress, which increased with age, has been noted in the literature [7, 8].
Reactive oxygen species (ROS) are widely considered to be a causal factor not only in aging but in a number of pathological conditions, including abnormal cell proliferation and carcinogenesis. Aging, considered as an impairment of body functions over time, caused by the accumulation of molecular damage in deoxyribonucleic acid (DNA), proteins and lipids, is also characterized by an increase in intracellular oxidative stress due to the monotonic decrease of intracellular ROS scavenging with age [7]. Oxidative damage to cellular macromolecules which induce cancer can also arise through overproduction of ROS and faulty antioxidant and/or DNA repair mechanisms [12]. Overproduction of ROS is associated with inflammation, radiation, and other factors, including overload of some chemical elements, in both blood and certain tissues, or deficiency in chemical elements with antioxidant properties [13–19]. Studies have shown that the imbalance in the composition of chemical elements may cause different types of pathology. The importance of appropriate levels of many chemical elements is indisputable, due to their beneficial roles when in specific concentration ranges; while on the other hand, they can cause toxic effects with excessively high or low concentrations [16].
About 50 years ago, a postulate of trace element homeostasis in human body tissues and fluids in normal environmental and health conditions was formulated [16]. It was supposed that the homeostatic levels of chemical elements depend on many factors such as gender, age, race, diet, unhealthy lifestyle habits, climate, biogeochemical and environmental characteristics of habitation, occupational exposure to certain chemical compounds, and so on [16]. It was also supposed that all chemical elements are actively or inactively involved in normal metabolism of human body tissues and fluids and that a deficiency, or an excess, of some of them, as well as an imbalance of chemical element contents, could be a causative factor for many diseases, including cancer [16].
In our previous studies, high mass fractions of Al, Au, B, Ba, Br, Ca, Cl, Cr, Ga, Li, Mg, Na, Ni, Sr, U, and Zn were observed in nonhyperplastic prostate tissues of adult males, when compared with levels in nonprostatic soft tissues of the human body [20–23]. Moreover, it was shown that the levels of Zn and some other chemical elements in prostate tissue are androgen-dependent parameters [24–29]. The mass fractions of these elements in prostate tissue jump up during puberty and continue to increase in young adult males. However, some questions about the age dependence of chemical element mass fraction in prostate glands of adult and, particularly, elderly males (≥61 years old) still remain unanswered.
The main epidemiologic associative factor of BPH and PCa is age, and the prevalence of these diseases increases dramatically after 40 years. One valuable way to elucidate the situation is to compare the prostatic mass fractions of chemical elements in young adult (the norm) with those in older adult and geriatric prostate. Carcinogenesis is considered to have four stages: initiation, promotion, progression, and metastasis. Thus, the findings of the excess or deficiency of prostatic chemical element contents and the perturbations of their relative proportions in nonhyperplastic prostate glands of adult and elderly males may give an indication of their role in at least two stages of carcinogenesis: initiation and promotion.
The data available on chemical element mass fractions in geriatric nonhyperplastic prostate is extremely limited [30–32]. There are many studies regarding chemical element content in prostate of adult males, using chemical techniques and instrumental methods [33–59]. However, the majority of these data are based on measurements of processed tissue, and in many studies, tissue samples are ashed before analysis. In other cases, prostate samples are treated with solvents (distilled water, ethanol etc.) and then are dried at a high temperature for many hours. There is evidence that certain quantities of chemical elements are lost as a result of such treatment [60, 61]. Moreover, only a few of these studies employed quality control using certified reference materials (CRM) for determination of the chemical element mass fractions.
We define three age groups for prostates in our study; groups 1 (from young adults aged 21 to 40 years), 2 (from adults aged 41 to 60 years), and 3 (from elderly adults aged 61 to 87 years). The primary purpose of this study was to determine reliable values for chemical element mass fractions in the nonhyperplastic prostate of subjects of different age from young adult to elderly persons using five analytical methods: an energy dispersive X-ray fluorescence (EDXRF), an instrumental neutron activation analysis with high resolution spectrometry of short-lived (INAA-SLR) and long-lived (INAA-LLR) radionuclides, an inductively coupled plasma atomic emission spectrometry (ICP-AES), and an inductively coupled plasma mass spectrometry (ICP-MS). The second aim was to compare the chemical element mass fractions in prostate glands of our age group 1 with those of group 2 and 3. The final aim was to compare the results of this study with reference data for nonhyperplastic prostate gland of adult males of all ages.
All studies were approved by the Ethical Committee of the Medical Radiological Research Centre, Obninsk.
Materials and Methods
Samples of the human prostate were obtained from randomly selected autopsy specimens of 65 males (European-Caucasian) aged 21 to 87 years. All samples were obtained within 24 h after death. Age ranges for subjects were divided into the three age groups defined above, with group 1 (30.4 ± 1.1 years, M ± SEM, n = 28), group 2 (49.6 ± 1.1 years, M ± SEM, n = 27), and group 3 (68.8 ± 2.7 years, M ± SEM, n = 10). These groups were selected to reflect the condition of prostate of young adult, mid-adult, and elderly adult. The available clinical data were reviewed for each subject. None of the subjects had a history of an intersex condition, endocrine disorder, neoplasm, or other chronic disease that could affect the normal development of the prostate. None of the subjects were receiving medications known to affect prostate morphology, metabolism, or its trace element content. The typical causes of death of most of these patients included acute illness (cardiac insufficiency, stroke, embolism of pulmonary artery, alcohol poisoning) and trauma. All prostate glands were divided (with an anterior-posterior cross-section) into two portions using a titanium scalpel. One tissue portion was reviewed by an anatomical pathologist, while the other was used for the chemical element content determination. Only the posterior part of the prostate, including the transitional, central, and peripheral zones, was investigated. A histological examination was used to control the age norm conformity as well as to confirm the absence of any microadenomatosis and/or latent cancer.
After the samples intended for chemical element analysis were weighed, they were freeze-dried and homogenized. The pounded sample weighing about 8 mg was applied to a piece of adhesive tape, which served as a sample backing for EDXRF analysis. The sample weighing about 100 mg was used for chemical element measurement by instrumental NAA-SLR. The samples for INAA-SLR were sealed separately in thin polyethylene films washed with acetone and rectified alcohol beforehand. The sealed samples were placed in labeled polyethylene ampoules. A sample weighing about 50 mg was used for chemical element measurement by instrumental NAA-LLR. The samples for INAA-LLR were wrapped separately in a high-purity aluminum foil washed with rectified alcohol beforehand and placed in a nitric acid-washed quartz ampoule.
The samples weighing about 100 mg for ICP-AES and ICP-MS were decomposed in autoclaves; 1.5 mL of concentrated HNO3 (nitric acid at 65 %, maximum of 0.0000005 % Hg; GR, ISO, Merck) and 0.3 mL of H2O2 (pure for analysis) were added to the prostate tissue samples, placed in one-chamber autoclaves (Ancon-AT2, Ltd., Russia), and then heated for 3 h at 160–200 °C. After autoclaving, they were cooled to room temperature, and solutions from the decomposed samples were diluted with deionized water (up to 20 mL) and transferred to plastic measuring bottles. Simultaneously, the same procedure was performed in autoclaves without tissue samples (only HNO3 + H2O2 + deionized water), and the resultant solutions were used as control samples.
For quality control, samples of the certified reference materials IAEA H-4 Animal Muscle from the International Atomic Energy Agency (IAEA) and also samples of INCT-SBF-4 Soya Bean Flour, INCT-TL-1 Tea Leaves, and INCT-MPH-2 Mixed Polish Herbs from the Institute of Nuclear Chemistry and Technology (INCT, Warsaw, Poland) were analyzed simultaneously with the prostate tissue samples being investigated. All samples of CRM were treated in the same way as the prostate tissue samples. Detailed results of this quality assurance program were presented in earlier publications [20–23, 25].
The mass fractions of Br, Fe, Rb, Sr, and Zn were measured by EDXRF; the mass fractions of Br, Ca, Cl, K, Mg, Mn, and Na by NAA-SLR; the mass fractions of Ag, As, Au, Ba, Br, Cd, Ce, Co, Cr, Cs, Eu, Fe, Gd, Hf, Hg, La, Lu, Nd, Rb, Sb, Sc, Se, Sm, Sr, Ta, Tb, Th, U, Yb, Zn, and Zr by NAA-LLR; the mass fractions of Al, B, Ba, Ca, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Si, Sr, and Zn by ICP-AES; and the mass fractions of Ag, Al, As, Au, B, Be, Bi, Br, Cd, Ce, Co, Cr, Cs, Dy, Er, Eu, Ga, Gd, Hf, Hg, Ho, Ir, La, Li, Lu, Mn, Mo, Nb, Nd, Ni, Pb, Pd, Pr, Pt, Rb, Re, Sb, Se, Sm, Sn, Ta, Tb, Te, Th, Ti, Tl, Tm, U, Y, Yb, Zn, and Zr by ICP-MS. Details of the analytical methods and procedures used here such as nuclear reactions, radionuclides, gamma-energies, wavelength, isotopes, spectrometers, spectrometer parameters, and operating conditions were presented in our earlier publications concerning the chemical elements of human prostate gland [20–23, 25].
A dedicated computer program of INAA mode optimization was used [62]. Using the Microsoft Office Excel program to provide a summary of statistical results, the arithmetic mean, standard deviation, standard error of mean, minimum and maximum values, median, and percentiles with 0.025 and 0.975 levels were calculated for all the chemical element mass fractions obtained. For elements investigated by two or more methods, the mean of all results was used. The reliability of difference in the results between two age groups of different group pairs was evaluated by Student’s parametric t test. For the construction of “chemical element mass fraction versus age” diagrams, the Microsoft Office Excel program was also used.
Results
Table 1 depicts the results obtained for 67 elemental mass fractions (arithmetic mean ± standard deviation, possible upper limit of the mean, detection limit) in nonhyperplastic prostate glands of males in the age range 21–87 years measured by means of the five analytical methods described above. The mass fractions of As, Eu, Ga, Hf, Ir, Lu, Pd, Pt, Re, Ta, and V (11 trace elements) were determined only for the few samples collected. The possible upper limit of the mean (≤M) for these elements was calculated as the average mass fraction for each element, using the value of the detection limit (DL) instead of the individual value, when the latter was found to be below the DL:
where C i is the individual value of chemical element mass fraction in the ith sample, n i is the number of samples with a measured mass fraction above DL, n j is the number of samples with a measured mass fraction below DL, and n = n i + n j is the total number of investigated samples. Generally, the mass fractions of Rh and Te were lower than the corresponding DL (in mg/kg on a dry mass basis) <0.01 and <0.003, respectively.
To analyze the effect of age on the chemical element mass fractions in the prostate glands, we examined the three age groups, described above. Tables 2, 3, 4, and 5 present basic statistical parameters (arithmetic mean, standard deviation, standard error of mean, minimal and maximal values, median, and percentiles with 0.025 and 0.975 levels) of the Ag, Al, Au, B, Ba, Be, Bi, Br, Ca, Cd, Ce, Cl, Co, Cr, Cs, Cu, Dy, Er, Fe, Gd, Hg, Ho, K, La, Li, Mg, Mn, Mo, Na, Nb, Nd, Ni, P, Pb, Pr, Rb, S, Sb, Sc, Se, Si, Sm, Sn, Sr, Tb, Th, Ti, Tl, Tm, U, Y, Yb, Zn, and Zr mass fractions (mg/kg, dry mass basis) in adult and geriatric prostate glands of males in the age range 21–40 years (group 1), 41–60 years (group 2), 61–87 years (group 3), and 41–87 years (groups 2 and 3, combined), respectively. The contents of these 54 elements were measured in all, or a major portion, of prostate tissue samples. The ratios of means and the reliability of difference between mean values of chemical element mass fraction in two age groups of the different group pairs are presented in Table 6.
Figure 1 shows individual data set for the Ba, Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, U, and Zn mass fraction in the nonhyperplastic prostate gland of males aged between 21 and 87 years and their trend lines with equations of best fit. In our study, the best fit in the proportion variance accounted for (i.e., R2) sense maximizes the value of R2 using a linear, exponential, logarithmic, power, or polynomial law.
To compare our results with published data for the chemical element mass fractions in the prostate gland of adults, we examined all our prostate data of males aged 21–87 years. The comparison of our results with published data for the 67 chemical element mass fractions (mg/kg, dry mass basis) in the prostate of adult males is shown in Table 7. Because some values for chemical element mass fractions were not expressed on a dry mass basis in other’s publications, we recalculated these values using published data for water—83 % [63] and ash—1.0 % [64] contents in the prostate of adult men.
Discussion
The use of five analytical methods allowed us to estimate the mass fractions of 67 elements in nonhyperplastic adult and geriatric prostate glands of males in the age range 21–87 years. Good agreement (Table 1) was found between the results obtained with nondestructive (EDXRF, NAA-SLR, and NAA-LLR) and destructive methods (ICP-AES and ICP-MS) for Ag, Br, Ca, Co, Cr, Fe, K, Mg, Mn, Na, Rb, Sb, Se, Sr, and Zn indicating complete digestion of the prostate samples (for ICP techniques) and correctness of all results obtained by the various methods (Tables 2, 3, 4, and 5). The fact that the elemental mass fractions (M ± SD) of the certified reference materials obtained in the present work were in good agreement with the certified values and within the corresponding 95 % confidence intervals [20–23, 25] suggests an acceptable accuracy of the measurements performed on our prostate tissue samples.
The mass fractions for 54 chemical elements listed in Tables 2, 3, 4, and 5 (Ag, Al, Au, B, Ba, Be, Bi, Br, Ca, Cd, Ce, Cl, Co, Cr, Cs, Cu, Dy, Er, Fe, Gd, Hg, Ho, K, La, Li, Mg, Mn, Mo, Na, Nb, Nd, Ni, P, Pb, Pr, Rb, S, Sb, Sc, Se, Si, Sm, Sn, Sr, Tb, Th, Ti, Tl, Tm, U, Y, Yb, Zn, and Zr) were measured in the total, or in a major portion, of the prostate samples investigated. This allowed calculation of the mean values and selected statistical features for these elements for all age groups.
In the histologically normal prostates, we have observed an increase (more than 10 %) in mass fraction of B, Bi, Ca, Cd, Ce, Cl, Co, Dy, Fe, Gd, Hg, Ho, La, Nb, Nd, Pb, Pr, Sc, Sm, Sn, Sr, Tb, Th, Ti, U, Y, and Zn with age from 21 to 60 years. In particular, a significant tendency of age-related increase in Bi (p ≤ 0.043), Cd (p ≤ 0.004), Co (p ≤ 0.039), Fe (p ≤ 0.012), Hg (p ≤ 0.029), Sc (p ≤ 0.019), Sn (p ≤ 0.007), U (p ≤ 0.050), and Zn (p ≤ 0.003) mass fractions was observed in prostate (Table 6). For example, in prostates of group 2, the Bi mass fractions were almost nine times, and the Cd, Hg, Sc, Sn, U, and Zn mass fractions were approximately 2–4 times, greater than in prostate of members of group 1 (Table 6).
From the comparison of the mass fraction means in the three age groups (Table 6), it followed that the mass fraction of Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, U, and Zn increased in the age range 21–60 years and reached a maximum somewhere in the sixth decade (Fig. 1). In the histologically normal prostates of men in the age range 61–87 years, the mass fractions of all these elements were maintained at approximately constant levels (after comparison between the age groups 2 and 3, Table 6). Thus, the main changes of chemical element contents with age in prostate tissue are found between the ages 21 and 60 years, but element mass fractions in the geriatric prostate hardly differ from those in prostate glands of adult males aged 41 to 60 years with the exception of Ba, La, Mo, Sn, and Ti. The Ba mass fraction increased, with statistical significance (Table 6, Fig. 1), for ages after 61 years. The La, Mo, Sn, and Ti mass fractions decreased with age after 60 years, in the comparison with those in the age range 41–60 years, but remained above values seen in the age range 21–40 years, with the exception of Mn and Mo (Table 6).
The prevalence of prostate diseases, particularly PCa, increases drastically after age 40 years [1, 2, 5–7]. Thus, because there is much interest in studying differences in chemical element contents before and after 40, the group 2 (41 to 60) and 3 (61 to 87) years were combined. From the comparison between the mass fraction means of group 1 with those in groups 2 and 3 combined (Table 6), it followed that the mass fractions of Bi (p ≤ 0.036), Cd (p ≤ 0.001), Co (p ≤ 0.024), Fe (p ≤ 0.009), Hg (p ≤ 0.050), Pb (p ≤ 0.050), Sc (p ≤ 0.015), Sn (p ≤ 0.007), Th (p ≤ 0.037), U (p ≤ 0.032), and Zn (p ≤ 0.0004) were statistically significant higher in the age range 41–87 years. It was not found, for any chemical element from the 67 investigated in this study, that the level of any elemental mass fraction was statistically significantly lower after the age of 40 years.
A change of Ba, Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, and Zn mass fractions in the prostate tissue with age from 21 to 87 years is more ideally fitted by a polynomial law (Fig. 1). An increase of Th and U mass fraction is more ideally fitted by a logarithmic law (Fig. 1).
The variations of the individual mass fractions of many chemical elements increased with age. This conclusion followed from the qualitative analysis of individual data sets (Fig. 1) and the quantitative comparison of the values of relative standard deviations (M/SD, %) in the age group 1 and 2 (Tables 2 and 3), for example, for Bi (54 % v 168 %), Hg (62 % v 76 %), Sn (82 % v 93 %), Th (67 % v 135 %), U (92 % v 145 %), and Zn (41 % v 73 %). Of course, individual variation of consumption of pharmaceuticals, dietary, environmental, occupational, and some other factors influence the levels of chemical elements in the prostate at different times during the lifespan. In addition, in our previous studies, it was shown that many chemical elements bind tightly with one of the histological structures of prostate glands such as stroma, epithelial cells, and glandular lumen [24, 38, 53, 65–67]. It was also found that the percent volumes of these histological structures depend from age and the individual uroflowmetric characteristics of the subject [68]. Moreover, the variations of the individual percent volumes of histological structures and uroflowmetric characteristics also increase with age [24, 67, 68].
The mean values obtained for the 67 chemical element mass fractions in adult and geriatric nonhyperplastic prostate glands (from adults aged 20–87 years) as shown in Table 7 agree well with median of means reported in the literature for the normal prostate tissue of adult males, including samples obtained from persons who died from different diseases. However, it must be remarked that the ranges of reported means, arising from both analytical uncertainty and individual variability of elemental mass fractions in the human prostate, are surprisingly wide (Table 7). For example, the “maximum mean/minimum mean” ratio for such elements as Ag, As, Au, B, Ba, Ca, Cd, Co, Cr, Cs, Cu, Fe, Hg, Mn, Mo, Na, Ni, Pb, Rb, Sb, Se, Sn, U, V, Y, and Zn is nearly equal one to five orders of magnitude.
This work’s results for age dependence of Ca, Cd, Cu, K, Na, P, and Zn mass fractions in nonhyperplastic prostate glands (for adult and geriatric persons aged 20–87 years) are in accordance with earlier findings [30–32, 44, 56, 69, 70]. For example, Hienzsch et al. [30] found that the Zn mass fraction in the normal prostate was higher in the age group 51–70 years than in the age group 31–50 years by approximately 1.8 times and somewhat lower (but the difference was not statistically significant) in the age group 71–90 years, compared with the age group 51–70 years. An increase of Cd mass fraction in the prostate tissue with age was found by Hienzsch et al. [69], Oldereid et al. [56], and Schöpfer et al. [44]. In accordance with Tohno et al. [32], there were no significant correlations between age and the Fe, Mg, Na, and Zn mass fractions in prostate tissue of Thai subjects, whose ages ranged from 43 to 86 years, and of Japanese subjects, with age from 65 to 101 years. These conclusions agree with our results.
In our earlier publications, it was discussed in detail [13, 15, 67] that the age-related excessive Zn level in prostatic tissue is probably one of the main factors influencing the enlargement of the prostate gland, as well as the initiation and progression of PCa. In addition to the elevated Zn level, an age-related increase and excess in Ba, Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, and U mass fractions in prostatic tissue may contribute to harmful effects on the gland. There are good reasons for such speculations since many reviews and numerous papers raise the concern about toxicity and carcinogenicity of these metals [71–85]. Each of these metals is distinct in its primary mode of action. Moreover, there are several forms of synergistic action of these metals as a part of intracellular metabolism, during which several reactive intermediates and byproducts are created [71, 72, 82]. These reactive species are capable of potent and surprisingly selective activation of stress-signaling pathways, inhibition of DNA metabolism, repair, and formation of DNA crosslinks, which are known to contribute to the development of human cancers [72, 74, 78]. In addition to genetic damage via both oxidative and nonoxidative (DNA adducts) mechanisms, metals can also cause significant changes in DNA methylation and histone modifications, leading to alterations in gene expression [74, 75, 77, 81]. In vitro and animal carcinogenic studies provided strong support for the idea that metals can also act as co-carcinogens in combination with nonmetal carcinogens [74, 83].
Multiple studies put forward an idea that due to lifestyle, dietary habits, and physiological effects of aging, the elderly male population is predisposed to Ca, Cu, Fe, Mg, Se, Zn, and some other chemical element deficiencies [86–90], which can increase this population’s susceptibility to BPH and PCa [91]. Our data reveal that there are no age-related deficiencies in Ca, Cu, Fe, Mg, Se, Zn, and other chemical elements investigated in the prostate tissue. Moreover, the mean mass fractions of Ca, Fe, Se, and Zn for the group of adult males aged 41 years and older are higher than for those younger than 40 years. Thus, “the potential role of age-related deficiency of Ca, Cu, Fe, Mg, Se, Zn” [91] or other chemical elements in the prostate has not been confirmed by us as being involved in the etiology of BPH and PCa.
Conclusion
The combination of nuclear and inductively coupled plasma analytical methods allows an estimation of the contents of no less than 67 chemical elements and a precise determination of the mass fraction of 54 elements in the tissue samples of nonhyperplastic adult and geriatric prostate glands.
This work’s results reveal that there is a significant tendency for an increase in Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, U, and Zn mass fractions in the prostate tissue of healthy individuals, as their ages vary from 21 up to 60 years, as well as an increase in prostatic Ba from age 61 up to 87 years. These findings imply that an age-related increase and excess in Ba, Bi, Cd, Co, Fe, Hg, Pb, Sc, Sn, Th, U, and Zn mass fraction in prostatic tissue may be one of the main factors in the etiology of BPH and PCa.
The mean values obtained for the 67 chemical element mass fractions in adult and geriatric nonhyperplastic prostate glands agree well with median of means reported in the literature. However, the ranges of reported means are extremely wide.
All the prostates studied had normal morphology and were obtained from subjects without systematic or chronic disorders. Thus, our data for 54 chemical element mass fractions in nonhyperplastic adult and geriatric prostate glands at least may serve as indicative normal values for an urban population of the Russian Central European region.
The data obtained in the present study may also prove very valuable for many different applications in environmental and occupational medicine, medical radiology, radiation protection, radiotherapy dosimetry, and other scientific fields.
References
Bonkhoff H, Remberger K (1998) Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma. Pathologe 19:12–20
Schauer IG, Rowley DR (2011) The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 82:200–210
Carson C, Rittmaster R (2003) The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 61(4 Suppl 1):2–7
Lee KL, Peehl DM (2004) Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 172:1784–1791
Lepor H (2005) Pathophysiology of benign prostatic hyperplasia in the aging male population. Rev Urol 7(Suppl 4):S3–S12
Soulitzis N, Karyotis I, Delakas D, Spandidos DA (2006) Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol 29:305–314
Minelli A, Bellezza I, Conte C, Culig Z (2009) Oxidative stress-related aging: a role for prostate cancer? Biochim Biophys Acta 1795:83–91
Przybyszewski WM, Rzeszowska-Wolny J (2009) Oxidative stress in prostate hypertrophy and carcinogenesis. Postepy Hig Med Dosw 63:340–350
Ho CKM, Habib FK (2011) Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol 8:29–41
Meeks JJ, Schaeffer EM (2011) Genetic regulation of prostate development. J Androl 32:210–217
Patel ND, Parsons JK (2014) Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol 30:170–176
Klaunig JE, Kamendulis LM, Hocevar BA (2010) Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38:96–109
Zaichick V, Zaichick S (1999) Role of zinc in prostate cancerogenesis. In: Anke M et al (eds) Mengen und Spurenelemente. 19. Arbeitstagung. Friedrich-Schiller-Universitat, Jena, p 104–115
Järup L (2003) Hazards of heavy metal contamination. Br Med Bull 68:167–182
Zaichick V (2004) INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate. J Radioanal Nucl Chem 262:229–234
Zaichick V (2006) Medical elementology as a new scientific discipline. J Radioanal Nucl Chem 269:303–309
Toyokuni S (2008) Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 60(7):441–447
Gupte A, Mumper RJ (2009) Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 35:32–46
Lee JD, Wu SM, Lu LY, Yang YT, Jeng SY (2009) Cadmium concentration and metallothionein expression in prostate cancer and benign prostatic hyperplasia of humans. J Formos Med Assoc 108:554–559
Zaichick S, Zaichick V (2011) The Br, Fe, Rb, Sr, and Zn content and interrelation in intact and morphologic normal prostate tissue of adult men investigated by energy dispersive X-ray fluorescent analysis. X-Ray Spectrom 40:464–469
Zaichick S, Zaichick V (2011) The effect of age on Ag, Co, Cr, Fe, Hg, Sb, Sc, Se, and Zn contents in intact human prostate investigated by neutron activation analysis. Appl Radiat Isot 69:827–833
Zaichick V, Nosenko S, Moskvina I (2012) The effect of age on 12 chemical element contents in the intact prostate of adult men investigated by inductively coupled plasma atomic emission spectrometry. Biol Trace Elem Res 147:49–58
Zaichick S, Zaichick V, Nosenko S, Moskvina I (2012) Mass fractions of 52 trace elements and zinc trace element content ratios in intact human prostates investigated by inductively coupled plasma mass spectrometry. Biol Trace Elem Res 149:171–183
Zaichick S, Zaichick V (2013) Relations of morphometric parameters to zinc content in paediatric and nonhyperplastic young adult prostate glands. Andrology 1:139–146
Zaichick V, Zaichick S (2013) The effect of age on Br, Ca, Cl, K, Mg, Mn, and Na mass fraction in pediatric and young adult prostate glands investigated by neutron activation analysis. Appl Radiat Isot 82:145–151
Zaichick V, Zaichick S (2013) INAA application in the assessment of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn mass fraction in pediatric and young adult prostate glands. J Radioanal Nucl Chem 298:1559–1566
Zaichick V, Zaichick S (2013) NAA-SLR and ICP-AES application in the assessment of mass fraction of 19 chemical elements in pediatric and young adult prostate glands. Biol Trace Elem Res 156:357–366
Zaichick V, Zaichick S (2013) Use of neutron activation analysis and inductively coupled plasma mass spectrometry for the determination of trace elements in pediatric and young adult prostate. Am J Anal Chem 4:696–706
Zaichick V, Zaichick S (2014) Androgen-dependent chemical elements of prostate gland. Androl Gynecol: Curr Res 2(2):1–9. doi:10.4172/2327-4360.1000121
Hienzsch E, Schneider H-J, Anke M (1970) Vergleichende Untersuchungen zum Mengen- und Spurenelementgehalt der normalen Prostata, des Prostataadenoms und des Prostatakarzinoms. Z Urol Nephrol 63:543–546
Leissner KM, Fielkegard B, Tisell LE (1980) Concentration and content of zinc in human prostate. Investig Urol 18:32–35
Tohno S, Kobayashi M, Shimizu H, Tohno Y, Suwannahoy P, Azuma C, Minami T, Sinthubua A, Mahakkanukrauh P (2009) Age-related changes of the concentrations of select elements in the prostates of Japanese. Biol Trace Elem Res 127:211–227
Tipton IH, Cook MJ (1963) Trace elements in human tissue. Part II. Adult subjects from the United States. Health Phys 9:103–145
Tipton JH, Steiner RL, Foland WD, Mueller J, Stanley M (1954) USAEC-ORNL-Report-CF-54-12-66
Stitch SR (1957) Trace elements in human tissue. I. A semi-quantitative spectrographic survey. Biochem J 67:97–103
Neslund-Dudas C, Kandegedara A, Kryvenko ON, Gupta N, Rogers C, Rybicki BA, Ping Dou Q, Mitra B (2014) Prostate tissue metal levels and prostate cancer recurrence in smokers. Biol Trace Elem Res 157:107–112
Liebscher K, Smith H (1968) Essential and nonessential trace elements. A method of determining whether an element is essential or nonessential in human tissue. Arch Environ Health 17:882–891
Zaichick V, Zaichick S (2014) The distribution of 54 trace elements including zinc in pediatric and nonhyperplastic young adult prostate gland tissues. J Clin Lab Investig Update 2(1):1–15
Jaritz M, Anke M, Holzinger S (1998) Der Bariumgehalt verschiedener Organe von Feldhase, Wildschwein, Damhirsch, Reh, Rothirsch, Mufflon and Mensch. In: Anke M et al (eds) Mengen- und Spurenelemente. 18. Arbeitstagung. Friedrich-Schiller-Universität, Jena, p 467–474
Zaichick V, Zaichick S (2014) Use of INAA and ICP-MS for the assessment of trace element mass fractions in adult and geriatric prostate. J Radioanal Nucl Chem 301:383–397
Kubo H, Hashimoto S, Ishibashi A, Chiba R, Yokota H (1976) Simultaneous determinations of Fe, Cu, Zn, and Br concentrations in human tissue sections. Med Phys 3:204–209
Zaichick S, Zaichick V (2010) Method and portable facility for energy-dispersive X-ray fluorescent analysis of zinc content in needle-biopsy specimens of prostate. X-Ray Spectrom 39:83–89
Schneider H-J, Anke M, Holm W (1970) The inorganic components of testicle, epididymis, seminal vesicle, prostate and ejaculate of young men. Int Urol Nephrol 2:419–427
Schöpfer J, Drasch G, Schrauzer GN (2010) Selenium and cadmium levels and ratios in prostates, livers, and kidneys of nonsmokers and smokers. Biol Trace Elem Res 134:180–187
Ogunlewe JO, Osegbe DN (1989) Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 63:1388–1392
Guntupalli JNR, Padala S, Gummuluri AVRM, Muktineni RK, Byreddy SR, Sreerama L, Kedarisetti PC, Angalakuduru DP, Satti BR, Venkatathri V, Pullela VBRL, Gavarasana S (2007) Trace elemental analysis of normal, benign, hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique. Eur J Cancer Prev 16:108–115
Zaichick V, Zaichick S (2014) INAA application in the assessment of chemical element mass fractions in adult and geriatric prostate glands. Appl Radiat Isot 90:62–73
Banaś A, Kwiatek WM, Zając W (2001) Trace element analysis of tissue section by means of synchrotron radiation: the use of GNUPLOT for SRIXE spectra analysis. J Alloys Compd 328:135–138
Forssen A (1972) Inorganic elements in the human body. I. Occurrence of Ba, Br, Ca, Cd, Cs, Cu, K, Mn, Ni, Sn, Sr, Y and Zn in the human body. Ann Med Exp Biol Fenn (Finland) 50:99–162
Anspaugh LR, Robinson WL, Martin WH, Lowe OA (1973) Compilation of published information on elemental concentrations in human organs in both normal and diseased states. No. UCRL-51013Pt. 1971-1973, p 1–4
Jafa A, Mahendra NM, Chowdhury AR, Kamboj VP (1980) Trace elements in prostatic tissue and plasma in prostatic diseases of man. Indian J Cancer 17:34–37
Sangen H (1967) The influence of the trace metals upon the aconitase activity in human prostate glands. Jpn J Urol 58:1146–1159
Zaichick V, Zaichick S (2014) Relations of the Al, B, Ba, Br, Ca, Cl, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Si, Sr, and Zn mass fractions to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands. BioMetals 27:333–348
Soman SD, Joseph KT, Raut SJ, Mulay GD, Parameswaran M, Pandey VK (1970) Studies of major and trace element content in human tissues. Health Phys 19:641–656
Koch HJ, Smith ER, Shimp NF, Connor J (1956) Analysis of trace elements in tissue. I. Normal tissue. Cancer 9:499–511
Oldereid NB, Thomassen Y, Attramadal A, Olaisen B, Purvis K (1993) Concentrations of lead, cadmium and zinc in the tissues of reproductive organs of men. J Reprod Fertil 99:421–425
Belt TH, Irwin D, King EJ (1936) Silicosis and dust deposits in the tissues of person without occupational exposure to siliceous dusts. Can Med Assoc J 34:125–133
Höffken B, Rausch-Stroomann JG (1969) Excretion of zinc in diabetics receiving penicillamine. Z Klin Chem Klin Biochem 7:4–7
Galván-Bobadilla AI, García–Escamilla RM, Gutiérrez-García N, Mendoza-Magaña ML, Rosiles-Martínez R (2005) Cadmium and zinc concentrations in prostate cancer and benign prostate hyperplasia. Rev Latinoam Patol Clin 52:109–117
Zaichick V (1997) Sampling, sample storage and preparation of biomaterials for INAA in clinical medicine, occupational and environmental health. In: Harmonization of Health-Related Environmental Measurements Using Nuclear and Isotopic Techniques. IAEA, Vienna, p 123–133
Zaichick V (2004) Losses of chemical elements in biological samples under the dry ashing process. Trace Elem Med (Moscow) 5(3):17–22
Korelo AM, Zaichick V (1993) Software to optimize the multielement INAA of medical and environmental samples. In: Activation Analysis in Environment Protection. Join Institute of Nuclear Research, Dubna, Russia, p 326–332
Marezynska A, Kulpa J, Lenko J (1983) The concentration of zinc in relation to fundamental elements in the diseases human prostate. Int Urol Nephrol 15:257–265
Saltzman BE, Gross SB, Yeager DW, Meiners BG, Gartside PS (1990) Total body burdens and tissue concentrations of lead, cadmium, copper, zinc, and ach in 55 human cadavers. Environ Res 52:126–145
Zaichick V, Zaichick S (2014) Relations of bromine, iron, rubidium, strontium, and zinc content to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands. Biol Trace Elem Res 157:195–204
Zaichick V, Zaichick S (2014) Relations of the neutron activation analysis data to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands. Adv Biomed Sci Eng 1(1):26–42
Zaichick V, Zaichick S (2014) Age-related histological and zinc content changes in adult nonhyperplastic prostate glands. Age 36:167–181
Zaichick V (2014) The prostatic urethra as a Venturi effect urine-jet pump to drain prostatic fluid. Med Hypotheses 83:65–68
Hienzsch E, Schneider H-J, Anke M, Hennig A, Groppel B (1979) The cadmium-, zinc-, copper-, and managanese-level of different organs of human beings without considerable Cd-exposure independence on age and sex. In: Anke M, Schneider H-J (eds) Kadmiumsymposium. Wissenschaftliche Beiträge der Friedrich-Schiller-Universität Jena, Jena, pp 276–282
Tisell LE, Fielkegard B, Leissner KM (1982) Zinc concentration and content of the dorsal, lateral and medical prostatic lobes and of periurethral adenomas in man. J Urol 128:403–405
Sunderman FW (1979) Mechanism of metal carcinogenesis. Biol Trace Elem Res 1:63–86
Snow ET (1992) Metal carcinogenesis: mechanistic implications. Pharmacol Ther 53:31–65
Chen XA, Cheng YE, Xiao H, Feng G, Deng YH, Feng ZL, Chen L, Han XM, Yang YJ, Dong ZH, Zheng R (2004) Health effects following long-term exposure to thorium dusts: a twenty-year follow-up study in China. Radioprotection 39:525–533
Salnikow K, Zhitkovich A (2008) Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21:28–44
Toyokuni S (2009) Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 100:9–16
Martinez-Zamudio R, Ha HC (2011) Environmental epigenetics in metal exposure. Epigenetics 6:820–827
Tokar EJ, Benbrahim-Tallaa L, Waalkes MP (2011) Metal ions in human cancer development. Met Ions Life Sci 8:375–401
Chervona Y, Arita A, Costa M (2012) Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 4:619–627
Clancy HA, Sun H, Passantino L, Kluz T, Muñoz A, Zavadil J, Costa M (2012) Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics 4:784–793
Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ (2012) Heavy metal toxicity and the environment. EXS 101:133–164
Byrne C, Divekar SD, Storchan GB, Parodi DA, Martin MB (2013) Metals and breast cancer. J Mammary Gland Biol Neoplasia 18:63–73
Koedrith P, Kim H, Weon JI, Seo YR (2013) Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity. Int J Hyg Environ Health 216:587–598
Lansdown ABG (2013) The carcinogenicity of metals: human risk through occupational and environmental exposure. RSC Publishing, Cambridge
Tabrez S, Priyadarshini M, Priyamvada S, Khan MS, Na A, Zaidi SK (2014) Gene–environment interactions in heavy metal and pesticide carcinogenesis. Mutat Res 760:1–9
Zhivin S, Laurier D, Guseva Canu I (2014) Health effects of occupational exposure to uranium: do physicochemical properties matter? Int J Radiat Biol 90:1104–1113
Mocchegiani E, Muaaioli M, Giacconi R (2000) Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 1:133–143
Ekmekcioglu C (2001) The role of trace elements for the health of elderly individuals. Nahrung 45:309–316
High KP (2001) Nutritional strategies to boost immunity and prevent infection in elderly individuals. Clin Infect Dis 33:1892–1900
Padro L, Benacer R, Foix S, Maestre E, Murillo S, Sanvicens E, Somoza D, Ngo J, Cervera P (2002) Assessment of dietary adequacy for an elderly population based on a Mediterranean model. J Nutr Health Aging 6:31–33
Vaquero MP (2002) Magnesium and trace elements in the elderly: intake, status and recommendations. J Nutr Health Aging 6:147–153
Sapota A, Daragó A, Taczalski J, Kilanowicz A (2009) Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions. BioMetals 22:1041–1049
Author information
Authors and Affiliations
Corresponding author
Additional information
This study is dedicated to the blessed memory of my good friend Professor Dr. Robert E. Jervis (University of Toronto), who was a Canadian pioneer in nuclear chemistry and application of nuclear analytical methods in the life sciences.
Rights and permissions
About this article
Cite this article
Zaichick, V. The Variation with Age of 67 Macro- and Microelement Contents in Nonhyperplastic Prostate Glands of Adult and Elderly Males Investigated by Nuclear Analytical and Related Methods. Biol Trace Elem Res 168, 44–60 (2015). https://doi.org/10.1007/s12011-015-0342-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-015-0342-3